The Institute of Chemical Biology & Drug Discovery (ICB&DD) at Stony Brook University is having its Ninth Annual Symposium, “Molecular Targets, Chemoprevention, and Cancer Therapeutics,” on Thursday, October 8, from 9:15 am to 5 pm in the Charles B. Wang Center. The IBC&DD Symposium focuses on cutting-edge advances in chemical biology, structural and computational biology, cancer and infectious diseases, and drug discovery. Renowned scholars in the field and highly recognized researchers on campus share their accomplishments and exchange innovative ideas among speakers, faculty, staff and students, as well as researchers at Brookhaven National Lab, academia and industry in the greater New York metropolitan area.
The plenary lecturers this year include:
Dr. Shaomeng Wang, Professor, Departments of Internal Medicine and Pharmacology, University of Michigan Medical School
Dr. Rajesh Agarwal, Professor, Department of Pharmaceutical Sciences, University of Colorado Cancer Center
Dr. Steven E. Rokita, Professor, Departments of Bioorganic Chemistry and Biochemistry, Johns Hopkins University
Dr. Kwok-Kin Wong, Professor, Harvard Medical School, Dana-Faber Cancer Institute
Dr. Patricia Thompson-Carino, Professor, Department of Pathology, Stony Brook University School of Medicine
Dr. Ravi Chari, Executive Director, Chemistry and Biochemistry, ImmunoGen Inc.
Dr. Geoffrey Girnun, Associate Professor, Department of Pathology, Stony Brook University School of Medicine
Poster sessions will display recently completed and ongoing projects conducted in the ICB&DD member’s laboratories and at relevant research labs in the area.
There is no registration fee, and the Symposium is open to all Stony Brook faculty, staff, students and postdocs that wish to attend. For more information, please visit the ICB&DD website.